Bristol Myers Squibb (BMY) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $1.08.
- Bristol Myers Squibb's EPS (Weighted Average and Diluted) rose 8000.0% to $1.08 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.96, marking a year-over-year increase of 18245.13%. This contributed to the annual value of -$4.41 for FY2024, which is 21424.87% down from last year.
- Latest data reveals that Bristol Myers Squibb reported EPS (Weighted Average and Diluted) of $1.08 as of Q3 2025, which was up 8000.0% from $0.64 recorded in Q2 2025.
- Bristol Myers Squibb's EPS (Weighted Average and Diluted)'s 5-year high stood at $1.2 during Q1 2025, with a 5-year trough of -$5.89 in Q1 2024.
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $0.83 (2024), whereas its average is $0.44.
- Per our database at Business Quant, Bristol Myers Squibb's EPS (Weighted Average and Diluted) soared by 127500.0% in 2021 and then tumbled by 65046.73% in 2024.
- Bristol Myers Squibb's EPS (Weighted Average and Diluted) (Quarter) stood at $1.07 in 2021, then dropped by 11.21% to $0.95 in 2022, then dropped by 8.42% to $0.87 in 2023, then crashed by 95.4% to $0.04 in 2024, then surged by 2600.0% to $1.08 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $1.08 for Q3 2025, versus $0.64 for Q2 2025 and $1.2 for Q1 2025.